Ovizio
Universiteit Gent

Ovizio

Deeptech
Deeptech
Deeptech
Deeptech

Acquired by ChemoMetec.

Ovizio is an innovative Belgian company developing efficient quantitative microscopy solutions for life science applications. Ovizio’s microscopes offer easy-to-use, label-free and non-invasive tools for real-time 3D imaging of living cells. Validated with
almost every type of transparent cell culture vessel, Ovizio’s devices can track cell density, cell morphology and cell viability with the highest reproducibility at a single cell level. Applicable from R&D to manufacturing processes and enabling significant
cost reductions and quality improvement, Ovizio’s microscopes are particularly convenient and robust for automated cell culture monitoring, analysis and quality control. Ovizio is a spinoff of the Université Libre de Bruxelles (ULB) and implements technology developed at Ghent University.

Acquired by ChemoMetec.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
THERAtRAME
Qbic III
Biotech
Biotech
Biotech
Biotech

THERAtRAME

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.

ULiège
Accelleran
Qbic II
Software
Software
Software
Software

Accelleran

Accelleran provides OpenRAN Software solutions for operators of 5G networks.

Universiteit Antwerpen
imec
moveUP
Qbic II
HealthTech
HealthTech
HealthTech
HealthTech

moveUP

moveUP develops personalized remote digital care for patients undergoing surgery and other interventions.

AZ Maria Middelares
VUB